COVID-19NCT06145386
"The Effect of Aerobic Exercise and Strength Training on Physical Activity Level, Quality of Life and Anxiety-Stress Disorder in Young Adults With and Without Covid-19"
A study testing Aerobic Exercise and Strength Training in people with COVID-19, run by Pamukkale University at 1 site in Turkey (Türkiye).
Trial summary
The purpose of this study; to examine the effects of aerobic and strength training on physical activity level, quality of life and anxiety-stress disorder in young adults with and without COVID-19. Read more about this study
- Who is it for?
- Ages 18 to 25 yearsHealthy volunteers can take part
- Conditions the study is for
- COVID-19
- What is being tested?
- Aerobic Exercise and Strength Training
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 30 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 21 Feb 2022to 19 Dec 2024
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 25 years
- All sexes
- Healthy volunteers accepted
- Adult
Who may be able to join
- Volunteering to participate in the study,
- Able to communicate, without hearing and/or visual impairment,
- Being between the ages of 18-25
- Not having a systemic disease
- Having had COVID-19 in the last 6 months to be included in the study group
Who cannot join
- Unable to communicate, hearing and/or visually impaired,
- Not being between the ages of 18-25
- Having a systemic disease other than COVID-19 infection,
- Having had COVID-19 more than 6 months ago.
Trial locations and contacts
1 site in 1 country.
Turkey (Türkiye)1 site
Istanbul Aydin University
Istanbul, Kücükcekmece
About this study
The purpose of this study; to examine the effects of aerobic and strength training on physical activity level, quality of life and anxiety-stress disorder in young adults with and without COVID-19. In this context, the study was planned by including 15 participants between the ages of 18-25 who had COVID-19 and 15 who did not have COVID-19. Data were collected by applying the Personal Data Form, IPAQ (International Physical Activity Form), SF-36 Quality of Life Scale, Coronavirus Anxiety Scale (CCS), Respiratory Function Tests (PFT), Six Minute Walk Test (6MWT). Aerobic training and strengthening training were applied to people with and without COVID-19 for 12 weeks. Aerobic exercise (walking) was given for 40 minutes 5 days a week, with the target heart rate being 70% of the age-corrected maximum heart rate. Strengthening exercises were applied to the upper (triceps, biceps, deltoid, pectorals) and lower (quadriceps, hamstring, gastrocnemius, tibialis anterior, hip adductors, hip flexors, hip extensors) extremities and back muscles (trapezius, latissimus dorsi) with theraband (resistance band). Significance test of the difference between two means in comparing independent group differences when parametric test assumptions are met for statistical analysis in line with the data collected from the participants; When parametric test assumptions are not met, Mann Whitney U test is used to compare independent group differences, while when parametric test assumptions are met to examine dependent group differences, the significance test of the difference between the two spouses is used; When parametric test assumptions were not met, the Wilcoxon paired two sample test was used. In all analyses, p < .05 was considered statistically significant.
- Conditions
- COVID-19
- Being tested
- Aerobic Exercise and Strength Training
- Keywords
- aerobic exercise, strength training, pulmonary capacity
- Medical subject headings
- COVID-19
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Aerobic Exercise and Strength TrainingBehavioural
Aerobic Exercise and Strength Training on Physical Activity Level, Quality of Life and Anxiety-Stress Disorder in Young Adults With and Without Covid-19
| Study group | Role | What they receive |
|---|---|---|
| COVID-19 positive | Experimental | Not described Receives: Behavioral: Aerobic Exercise and Strength Training |
| COVID-19 negative | Experimental | Not described Receives: Behavioral: Aerobic Exercise and Strength Training |
What is being measured
The primary outcome is the main question the study is designed to answer.
International Physical Activity Questionnaire
Used to define participants physical activity level
Measured: 5 minute
SF-36
Used to indicate the health status of participants
Measured: 10 minute
Coronavirus Anxiety Scale
Used to evaluate experience some psychological problems such as anxiety and depression depends on COVID-19
Measured: 1 minute
Respiratory Function Tests
Used to evaluation of the respiratory system
Measured: 5 minute
The 6 Minute Walk Test
Used to assess aerobic capacity and endurance
Measured: 6 minute
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted24 Nov 2023
- Study start21 Feb 2022
- Primary completion21 Apr 2023
- Study completion19 Dec 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for COVID-19Studies of the same condition, open and under way.
- More trials run by Pamukkale UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 30 participants (actual)
Sponsor and investigators
- Lead sponsor
- Pamukkale University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Ozge Mine Yilmaz, Pamukkale University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06145386
- Sponsor's protocol ID
- Pamukkale Universityy
- Status last verified
- Jan 2025
- First submitted
- 22 Nov 2023
- Last updated
- 24 Jan 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: If there is a reasonable request.
Study at a glance
From the registry record, last updated by the sponsor on 24 Jan 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- "The Effect of Aerobic Exercise and Strength Training on Physical Activity Level, Quality of Life and Anxiety-Stress Disorder in Young Adults With and Without Covid-19"
- ClinicalTrials.gov ID
- NCT06145386
- Acronym / sponsor ID
- Pamukkale Universityy
- Conditions
- COVID-19
- Keywords
- aerobic exercise, strength training, pulmonary capacity
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 30 participants (actual)
- Lead sponsor
- Pamukkale UniversityUniversity, hospital or other
- Study start
- 21 Feb 2022 (actual)
- Primary completion
- 21 Apr 2023 (actual)
- Study completion
- 19 Dec 2024 (actual)
- First posted
- 24 Nov 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study; to examine the effects of aerobic and strength training on physical activity level, quality of life and anxiety-stress disorder in young adults with and without COVID-19. In this context, the study was planned by including 15 participants between the ages of 18-25 who had COVID-19 and 15 who did not have COVID-19. Data were collected by applying the Personal Data Form, IPAQ (International Physical Activity Form), SF-36 Quality of Life Scale, Coronavirus Anxiety Scale (CCS), Respiratory Function Tests (PFT), Six Minute Walk Test (6MWT). Aerobic training and strengthening training were applied to people with and without COVID-19 for 12 weeks. Aerobic exercise (walking) was given for 40 minutes 5 days a week, with the target heart rate being 70% of the age-corrected maximum heart rate. Strengthening exercises were applied to the upper (triceps, biceps, deltoid, pectorals) and lower (quadriceps, hamstring, gastrocnemius, tibialis anterior, hip adductors, hip flexors, hip extensors) extremities and back muscles (trapezius, latissimus dorsi) with theraband (resistance band). Significance test of the difference between two means in comparing independent group differences when parametric test assumptions are met for statistical analysis in line with the data collected from the participants; When parametric test assumptions are not met, Mann Whitney U test is used to compare independent group differences, while when parametric test assumptions are met to examine dependent group differences, the significance test of the difference between the two spouses is used; When parametric test assumptions were not met, the Wilcoxon paired two sample test was used. In all analyses, p < .05 was considered statistically significant.
Study design
- Primary purpose
- Other
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| COVID-19 positive | Experimental | Behavioral: Aerobic Exercise and Strength Training |
| COVID-19 negative | Experimental | Behavioral: Aerobic Exercise and Strength Training |
Who may qualify
- Ages
- 18 to 25 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (5 listed)
- Volunteering to participate in the study,
- Able to communicate, without hearing and/or visual impairment,
- Being between the ages of 18-25
- Not having a systemic disease
- Having had COVID-19 in the last 6 months to be included in the study group
Key exclusion criteria (4 listed)
- Unable to communicate, hearing and/or visually impaired,
- Not being between the ages of 18-25
- Having a systemic disease other than COVID-19 infection,
- Having had COVID-19 more than 6 months ago.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Aerobic Exercise and Strength TrainingAerobic Exercise and Strength Training on Physical Activity Level, Quality of Life and Anxiety-Stress Disorder in Young Adults With and Without Covid-19 | Behavioural | COVID-19 negative, COVID-19 positive |
Primary outcome
International Physical Activity Questionnaire
Time frame: 5 minute
Used to define participants physical activity level
SF-36
Time frame: 10 minute
Used to indicate the health status of participants
Coronavirus Anxiety Scale
Time frame: 1 minute
Used to evaluate experience some psychological problems such as anxiety and depression depends on COVID-19
Respiratory Function Tests
Time frame: 5 minute
Used to evaluation of the respiratory system
The 6 Minute Walk Test
Time frame: 6 minute
Used to assess aerobic capacity and endurance
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 24 Jan 2025.
- Individual participant dataSharing planned: No. If there is a reasonable request.
Related trials for COVID-19
Not yet recruitingPhase 1
Phase I Open-Label Safety Trial of Pembrolizumab for Neurological Post- Acute Sequelae of SARS-CoV-2 (PD1-PASC I)
Post-Acute COVID-19 Syndrome
Active, not recruitingPhase 1
A Safety and Immunogenicity Trial of OCU500, ChAd36 Vector Encoding SARS-CoV-2 Spike Vaccine Via Intranasal and Inhalational Routes in Previously Vaccinated Adults
COVID-19
Active, not recruiting
Intervention to Address Disparate Mental Health Consequences of COVID-19 Pandemic on Latinx and African Newcomers
Mental Health Issue, Mental Health Disorder
Recruiting
Home-Based Exercise Tele-Rehabilitation After COVID-19
Post SARS-CoV2 (COVID-19)
Not yet recruitingPhase 1
A Safety, Reactogenicity and Immunogenicity Trial of RVX-sCPD9 Booster Intranasal COVID-19 Vaccine
COVID -19
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Aerobic Exercise and Strength Training in people with COVID-19, run by Pamukkale University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 24 Jan 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
International Physical Activity Questionnaire (time frame: 5 minute). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Jan 2025.